Shenshu Dingchuan Decoction Enhances Clinical Benefits of Budesonide/Formoterol in Chronic Bronchial Asthma Patients

Abstract

We have evaluated the clinical benefits of Shenshu Dingchuan decoction in chronic bronchial asthma patients treated with budesonide or formoterol. To this end, chronic bronchial asthma patients were divided into two groups and treated with budesonide or formoterol alone (the control group) or budesonide or formoterol plus Shenshu Dingchuan decoction (the treatment group). Shenshu Dingchuan decoction combined with budesonide formoterol decreased traditional Chinese medicine syndrome scores, elevated forced expiratory volume in one second, forced vital capacity, and forced expiratory volume in one second/forced vital capacity levels, decreased fractional exhaust nitric oxide and total immunoglobulin E levels, and the elevated total effective rate after treatment. In conclusion, these observed changes reflect a marked clinical improvement in lung function.